Igm Biosciences Stock Analysis
| IGMS Stock | USD 1.28 0.01 0.79% |
IGM Biosciences is undervalued with Real Value of 1.37 and Hype Value of 1.28. The main objective of IGM Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what IGM Biosciences is worth, separate from its market price. There are two main types of IGM Biosciences' stock analysis: fundamental analysis and technical analysis.
The IGM Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. IGM Biosciences is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. IGM Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IGM Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. IGM Stock Analysis Notes
About 38.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.27. IGM Biosciences had not issued any dividends in recent years. IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Igm Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people. To learn more about IGM Biosciences call Fred JD at 650 965 7873 or check out https://igmbio.com.IGM Biosciences Investment Alerts
| IGM Biosciences generated a negative expected return over the last 90 days | |
| IGM Biosciences may become a speculative penny stock | |
| IGM Biosciences has high historical volatility and very poor performance | |
| IGM Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.68 M. Net Loss for the year was (195.79 M) with loss before overhead, payroll, taxes, and interest of (129.42 M). | |
| IGM Biosciences currently holds about 469.14 M in cash with (153 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company shares are held by company insiders |
IGM Biosciences Upcoming and Recent Events
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
IGM Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 77.04 M.Technical Drivers
As of the 21st of July, IGM Biosciences retains the risk adjusted performance of (0.02), and Market Risk Adjusted Performance of 0.4387. IGM Biosciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out IGM Biosciences variance and potential upside to decide if IGM Biosciences is priced fairly, providing market reflects its last-minute price of 1.28 per share. Given that IGM Biosciences is a hitting penny stock territory we urge to closely look at its jensen alpha.IGM Biosciences Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of IGM Biosciences for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out IGM Biosciences short-term fluctuations and highlight longer-term trends or cycles.
IGM Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific IGM Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on IGM Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases IGM Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
IGM Biosciences Outstanding Bonds
IGM Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. IGM Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IGM bonds can be classified according to their maturity, which is the date when IGM Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
IGM Biosciences Predictive Daily Indicators
IGM Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of IGM Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
IGM Biosciences Forecast Models
IGM Biosciences' time-series forecasting models are one of many IGM Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IGM Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About IGM Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how IGM Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IGM shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as IGM Biosciences. By using and applying IGM Stock analysis, traders can create a robust methodology for identifying IGM entry and exit points for their positions.
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Igm Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding IGM Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.